Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kelly, R.
Right arrow Articles by Struthers, A.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, R.
Right arrow Articles by Struthers, A.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1999; 92: 295-297
© 1999 Association of Physicians

Editorial

Screening for left ventricular systolic dysfunction in patients with stroke, transient ischaemic attacks, and peripheral vascular disease

R. Kelly and A.D. Struthers

Department of Clinical Pharmacology Ninewells Hospital Dundee

Clinical heart failure is present in 0.4–2% of the population, and continues to rise as the population ages.1 Its impact is profound, accounting for 5% of all hospital admissions and 2% of all health expenditure.2–4 It has the greatest negative effect on quality of life of all chronic medical disorders and has a high mortality rate.5 In order to reduce the incidence of cardiac failure and all its consequences, we need to detect and treat presymptomatic left ventricular dysfunction (LVSD). We focus on a new way to screen for asymptomatic LVSD which is likely to be cost-effective.

LVSD is common and treatable, accounting for 8% of people aged 25–75 years; and 12% of 45–75-year-olds. Of the 8%, 4% are asymptomatic.6 Other surveys suggest the population prevalence of LVSD is 2.8–3.7%.7,8 The patients who appear to be . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
T. J. Wang, D. Levy, E. J. Benjamin, and R. S. Vasan
The Epidemiology of "Asymptomatic" Left Ventricular Systolic Dysfunction: Implications for Screening
Ann Intern Med, June 3, 2003; 138(11): 907 - 916.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Kelly, A. Staines, R. MacWalter, P. Stonebridge, H. Tunstall-Pedoe, and A. D. Struthers
The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: A case-control study
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 219 - 224.
[Abstract] [Full Text] [PDF]